<DOC>
	<DOCNO>NCT00242411</DOCNO>
	<brief_summary>The purpose study compare efficacy flexible dose Symbicort ( budesonide/formoterol ) conventional stepwise best standard treatment patient persistent asthma .</brief_summary>
	<brief_title>MONO : SymbicortÂ® Single Inhaler Therapy Conventional Best Standard Treatment Treatment Persistent Asthma Adolescents Adults</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Budesonide , Formoterol Fumarate Drug Combination</mesh_term>
	<mesh_term>Formoterol Fumarate</mesh_term>
	<mesh_term>Budesonide</mesh_term>
	<criteria>Diagnosis asthma &gt; = 3 month Prescribed daily use glucocorticosteroids least 3 month prior Visit 1 Smoking history &gt; 10 packyears Asthma exacerbation require change asthma treatment last 14 day prior inclusion Any significant disease disorder may jeopardize safety patient . Additional inclusion exclusion criterion evaluate investigator .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2011</verification_date>
</DOC>